Pure Global
NCT04039698

Monitoring of Hepatitis C Treatment Using Telemedicine - a Clinical Trial in Public Health System in Brazil

Monitoring of Hepatitis C Therapy Using Telemedicine in a Simplified Protocol With Pangenotypic Regimen in Non-cirrhotic Patients - a Single Group Clinical Trial in the National Public Health System in Brazil
Hospital de Clinicas de Porto Alegre·ClinicalTrials.gov·otherNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Chronic Hepatitis C
Drug/Device/Intervention
Telemedicine
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Hospital de Clinicas de Porto Alegre
Location
Porto Alegre, Brazil
Timeline & enrollment
Phase
N/A
Start date
Aug 23, 2019
End date
Nov 01, 2021
Enrollment
144 participants
Primary outcome

Sustained virologic response

Summary

The study is a non-randomized, single group clinical trial on monitoring hepatitis C therapy
 using telemedicine. Patients with chronic hepatitis C without cirrhosis will be treated with
 the pangenotypic regimen of direct acting antivirals sofosbuvir and velpatasvir for 12 weeks
 after a single visit to the clinic, in which treatment will be prescribed. Patients will be
 then monitored by telemedicine tools, like instant message application, telephone and video
 calls and by his or her primary physician when needed. Twelve weeks after treatment
 conclusion, hepatitis C virus RNA levels will be measured on a blood sample, indicating the
 cure rate and efficacy of this protocol on HCV treatment.
 
 The primary objective of the study is to address the feasibility and applicability of the
 usage of telemedicine tools to increase access and monitor HCV treatment with direct-acting
 antivirals in public health in Brazil.

ICD-10 classifications
Chronic viral hepatitis CAcute hepatitis CChronic viral hepatitisOther chronic viral hepatitisChronic hepatitis, unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT04039698
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT04039698 through Pure Global AI's free database. This phase not specified trial is sponsored by Hospital de Clinicas de Porto Alegre and is currently Not yet recruiting. The study focuses on Chronic Hepatitis C. Target enrollment is 144 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.